Trial Information

Status:

Specialty:

Prostate

Date Opened:

Planned Close date:

Sponsors:

Site Recruitment:

/

Principal Investigator:

Study Title:

INTENSIFY

Contacts

Research Nurse / Study Coordinator:

CancerClinicalTrialCoordinator

Administrator:

A phase III open label randomised trial of androgen deprivation therapy plus androgen receptor pathway inhibition, with or without docetaxel intensification, in metastatic prostate cancer with a PSA ≥0.2 ng/ml at 6 months (INTENSIFY)